Delivery Order SPE2DB22D9244-SPE2DB25FZS59
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,084.36 by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Actemra 400 mg/20 ml vials. This firm fixed-price delivery order is not associated with a set-aside designation and carries an ultimate completion date of August 25, 2025. The award represents a single line item delivery under DMS Pharmaceutical Group's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,923.36 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a pharmaceutical product, with an ultimate completion date of April 25, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, valued at up to $4,999,999 and held by DMS...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,903.32 firm fixed-price delivery order is for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML, with a completion date of December 14, 2021. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $7,308.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, with a period of performance through May 13, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999, which allows the DLA to issue delivery orders for a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $4,385.04 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The contract, which has no set-aside designation, is for the delivery of 4564299269 - Actemra Actpen 162 mg/0.9 ml 0.9ml syringes. This delivery order is part of a larger indefinite delivery contract (SPE2DB24FYW67) between DMS Pharmaceutical Group and DLA, valued at up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,759.56, is for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Actemra Actpen 162 mg/0.9 ml prefilled syringes. The $5,776 delivery order has a completion date of January 9, 2024 and was awarded on December 15, 2023. DMS Pharmaceutical Group will supply the pharmaceutical items to DLA Troop Support Medical facilities from its location in Park Ridge, Illinois. As a woman-owned small business,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,884.92 contract is for the delivery of ACTEMRA 162 MG/0.9 ML syringes to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $5,409.25 firm-fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product. The contract has an ultimate completion date of June 27, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,192.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a biologic medication used to treat certain autoimmune conditions. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with DLA, which...
- SPE2DB22D9244Indefinite Delivery Contract
- SPE2DB22D9244-SPE2DB25FZS59Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,313.27 by the Defense Logistics Agency (DLA) on August 19, 2025. The delivery order covers the supply of Actemra 400 mg/20 mL vials, a biologic medication used primarily for treating rheumatoid arthritis and other inflammatory conditions. This award was issued without a set-aside designation and is scheduled for completion by September 10, 2025, with performance to take place in Park Ridge, Illinois. This delivery order represents a continuation of DMS Pharmaceutical Group's substantial relationship with the DLA under the SPE2DB program, which maintains a single-award Indefinite Delivery Contract valued at $499,999,999 through November 2026. The company's longstanding partnership with the Defense Logistics Agency encompasses the distribution of a comprehensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to military health facilities nationwide. DMS Pharmaceutical Group's consistent receipt of delivery orders for specialized pharmaceutical products demonstrates its critical role in supporting the Department of Defense's medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 8/19/25 |